Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Yao‐Wen Cheng"'
Publikováno v:
JGH Open, Vol 6, Iss 12, Pp 846-853 (2022)
Abstract Background and Aim Up to a third of patients with inflammatory bowel disease (IBD) have elevated liver enzymes (ELE). We evaluated the incidence, predictors, and outcomes associated with ELE in a diverse and vulnerable IBD cohort. Methods We
Externí odkaz:
https://doaj.org/article/98998515e34946ffbcb2e6af336b77d5
Autor:
Vivek A. Rudrapatna, Yao-Wen Cheng, Colin Feuille, Arman Mosenia, Jonathan Shih, Yongmei Shi, Olivia Roberson, Benjamin Rubin, Atul J. Butte, Uma Mahadevan, Nicholas Skomrock, Ngozi Erondu, Christel Chehoud, Saquib Rahim, David Apfel, Mark Curran, Najat S. Khan, Christopher O’Brien, Natalie Terry, Benjamin D. Martini
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Background Randomized trials are the gold-standard for clinical evidence generation, but they can sometimes be limited by infeasibility and unclear generalizability to real-world practice. External control arm (ECA) studies may help address this evid
Externí odkaz:
https://doaj.org/article/787eb227a93741be9dac7c3b645b88b1
Autor:
Yao-Wen Cheng, Monika Fischer
Publikováno v:
Clinics in Colon and Rectal Surgery. 36:151-156
Fecal microbiota transplantation (FMT) is the process of transplanting stool from a healthy donor into the gut of a patient for therapeutic purposes. Current guidelines recommend FMT for the prevention of multiply recurrent Clostridioides difficile i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d970f5dcf2dd85615fe51f8cddf93cb1
https://doi.org/10.1055/s-0043-1760865
https://doi.org/10.1055/s-0043-1760865
Publikováno v:
Clinical Gastroenterology and Hepatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2588ceeeca577973b6075653c845da7b
https://doi.org/10.1016/j.cgh.2023.05.001
https://doi.org/10.1016/j.cgh.2023.05.001
Autor:
Connie W. Wang, Richard Mclean I, Yao-Wen Cheng, Stephanie Kim, Jonathan Terdiman, Priya Kathpalia, Kendall R. Beck
Publikováno v:
Digestive diseases and sciences, vol 68, iss 3
IntroductionThe coronavirus disease 19 (COVID-19) pandemic has disrupted healthcare delivery including elective endoscopy. We aimed to determine the prevalence of endoscopy cancellations in the COVID-19 era and identify patient characteristics associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726c210bb34509f0c5776a96e5b8324f
https://escholarship.org/uc/item/2c12364q
https://escholarship.org/uc/item/2c12364q
Autor:
Dana Alhaffar, Michael H. Woodworth, Matthew Bohm, Monika Fischer, Tanvi Dhere, Marwan Ghabril, Dina Kao, Lotem Nativ, Alexander Khoruts, Srishti Saha, Giovanni Cammarota, Sahil Khanna, Najwa El-Nachef, Sagi Sashidhar, Jenna Marcus, Colleen S. Kraft, Nirja Mehta, Byron P. Vaughn, Emmalee Phelps, Karen Wong, Nicholas Rogers, Gianluca Ianiro, Jessica R. Allegretti, Eric S. Orman, Huiping Xu, Yao-Wen Cheng
Publikováno v:
Clin Gastroenterol Hepatol
Clostridioides difficile infection (CDI) harms a large proportion of patients with cirrhosis. Fecal microbiota transplantation (FMT) is recommended for recurrent CDI, but its effects in patients with cirrhosis have not been established. We performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bc218a51f2fa8134f08ed9a4256be71
https://doi.org/10.1016/j.cgh.2020.06.051
https://doi.org/10.1016/j.cgh.2020.06.051
Autor:
Monika Fischer, Yao-Wen Cheng
Publikováno v:
Gastroenterology Clinics of North America. 49:739-752
"Patients with inflammatory bowel disease, including ulcerative colitis (UC) and Crohn disease, have altered gut microbiomes. The success of fecal microbiota transplantation (FMT) in the treatment of Clostridioides difficile infection, a disease that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfb4f59cc27881aca00a4818540648f9
https://doi.org/10.1016/j.gtc.2020.08.006
https://doi.org/10.1016/j.gtc.2020.08.006
Autor:
Monika Fischer, Yao Wen Cheng
Publikováno v:
Clinics in Colon and Rectal Surgery. 33:092-097
Fecal microbiota transplantation (FMT) is the process of transplanting stool from a healthy donor into the gut of a diseased individual for therapeutic purposes. It has a clearly defined role in the treatment of recurrent Clostridium difficile (recla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50654d20a1b9c0110df21b25670b5fab
https://doi.org/10.1055/s-0040-1701233
https://doi.org/10.1055/s-0040-1701233
Autor:
Monika Fischer, Yao-Wen Cheng
Publikováno v:
Expert Review of Anti-infective Therapy. 18:323-333
Introduction: Up to 15% of hospitalized patients with Clostridioides difficile infection (CDI) develop severe CDI (SCDI) or Fulminant CDI (FCDI). Due to high rates of mortality in medically-refractory CDI cases, 30% of patients with severe infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b39281b146fa28a47f67357e0f3b1f3a
https://doi.org/10.1080/14787210.2020.1730814
https://doi.org/10.1080/14787210.2020.1730814
Autor:
Ngozi Erondu, Mark Curran, Colin Feuille, Olivia Roberson, Jonathan Y. Shih, Yao-Wen Cheng, Benjamin E. Rubin, Saquib Rahim, Christel Chehoud, Yongmei Shi, David Apfel, Nicholas Skomrock, Najat S. Khan, Uma Mahadevan, Atul J. Butte, Vivek A. Rudrapatna, Arman Mosenia, Natalie A. Terry, Benjamin D Martini, Christopher D. O'Brien
Publikováno v:
PloS one, vol 18, iss 3
ObjectivesThe use of external control arms to study treatment effects is growing in interest among drug sponsors and regulators. However, experience with performing these kinds of studies for complex, immune-mediated diseases is limited. We sought to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07cbb0a3f68c0ec44a318ba6c579e45c
https://doi.org/10.1101/2021.11.12.21266064
https://doi.org/10.1101/2021.11.12.21266064